Search

Your search keyword '"John, Em"' showing total 771 results

Search Constraints

Start Over You searched for: Author "John, Em" Remove constraint Author: "John, Em"
771 results on '"John, Em"'

Search Results

1. Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors

2. Genome-wide meta-analyses of smoking behaviors in African Americans.

3. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

4. Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk

5. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers

6. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: A combined case-control study

7. Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study.

8. Phytoestrogen Consumption and Breast Cancer Risk in a Multiethnic PopulationThe Bay Area Breast Cancer Study

9. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

10. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

11. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

12. Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci

13. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.

14. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

15. Rare germline copy number variants (CNVs) and breast cancer risk

16. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

17. Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits

18. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score

19. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

20. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

21. Women's thoughts on receiving and sharing genetic information: Considerations for genetic counseling

22. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

23. Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholds

24. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

25. Genetic insights into biological mechanisms governing human ovarian ageing

26. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast

27. Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk

28. Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer

29. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

30. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

31. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

32. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

33. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

34. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk

35. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

36. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

37. Mammographic texture features associated with contralateral breast cancer in the WECARE Study

38. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

39. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

40. A competing risks model with binary time varying covariates for estimation of breast cancer risks in BRCA1 families

41. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

42. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

43. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

44. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

45. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

46. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

47. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

48. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

49. Identification of new breast cancer predisposition genes via whole exome sequencing

Catalog

Books, media, physical & digital resources